154 related articles for article (PubMed ID: 22375069)
1. Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice.
Beresford T; Fay T; Serkova NJ; Wu PH
J Pharmacol Exp Ther; 2012 Jun; 341(3):611-6. PubMed ID: 22375069
[TBL] [Abstract][Full Text] [Related]
2. Central Administration of Cyclosporine A Decreases Ethanol Drinking.
Ronan PJ; Strait SA; Palmer GM; Beresford TP
Alcohol Alcohol; 2018 Mar; 53(2):193-199. PubMed ID: 29281037
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response.
Rigol M; Solanes N; Sionis A; Gálvez C; Martorell J; Rojo I; Brunet M; Ramírez J; Roqué M; Roig E; Pérez-Villa F; Barquín L; Pomar JL; Sanz G; Heras M
J Heart Lung Transplant; 2008 Apr; 27(4):416-22. PubMed ID: 18374878
[TBL] [Abstract][Full Text] [Related]
4. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
[TBL] [Abstract][Full Text] [Related]
7. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
Gardiner SM; March JE; Kemp PA; Fallgren B; Bennett T
Br J Pharmacol; 2004 Feb; 141(4):634-43. PubMed ID: 14744807
[TBL] [Abstract][Full Text] [Related]
8. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of T-cell function for monitoring immunosuppression.
Barten MJ; Tarnok A; Garbade J; Bittner HB; Dhein S; Mohr FW; Gummert JF
Cell Prolif; 2007 Feb; 40(1):50-63. PubMed ID: 17227295
[TBL] [Abstract][Full Text] [Related]
10. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
Wulff BC; Kusewitt DF; VanBuskirk AM; Thomas-Ahner JM; Duncan FJ; Oberyszyn TM
J Invest Dermatol; 2008 Oct; 128(10):2467-73. PubMed ID: 18463679
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
Taylor PA; Lees CJ; Wilson JM; Ehrhardt MJ; Campbell MT; Noelle RJ; Blazar BR
Blood; 2002 Nov; 100(9):3400-7. PubMed ID: 12384443
[TBL] [Abstract][Full Text] [Related]
14. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
Barten MJ; Shipkova M; Bartsch P; Dhein S; Streit F; Tarnok A; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
Ther Drug Monit; 2005 Apr; 27(2):123-31. PubMed ID: 15795640
[TBL] [Abstract][Full Text] [Related]
16. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
18. Novel apoptosis assay to analyze immunosuppression.
Boldt A; Barten MJ; Weiss C; Sagner A; Mohr FW; Gummert JF
Cytometry A; 2006 Mar; 69(3):158-60. PubMed ID: 16479615
[TBL] [Abstract][Full Text] [Related]
19. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
